knowledge landing page image

KWM advises Agalimmune on the acquisition by NASDAQ

News - UK

Biotech - KWM advises Agalimmune on the acquisition by NASDAQ listed BioLineRx

KWM has advised client Agalimmune Ltd, a private UK-based company with an innovative, anti-cancer immunotherapy platform.

24 March 2017

Cross border KWM team secures major win in construction arbitration case

King & Wood Mallesons secured a major victory for a high profile Kuwaiti developer, owned by Kuwaiti Royals, in a USD 100 million construction arbitration case seated in...

07 March 2017

KWM advises Kyrgyz Republic on successful award overturn

KWM represented the Government of the Kyrgyz Republic to successfully overturn the US$16.5 million UNCITRAL award

28 February 2017

KWM advises on the private placement of a stake in Ugandan power company Umeme Limited

KWM advised Stanbic Bank Uganda Limited and SBG Securities Limited in connection with the private placement by Umeme Holdings Limited of its 14.3 % stake in the Ugandan...

23 February 2017

King & Wood Mallesons scores a major victory for Ukraine in an arbitration case

KWM scores a major victory for Ukraine in a US $270 million investment arbitration case relating to oil and gas taxation.

13 February 2017

King & Wood Mallesons’ plans for UK, Europe and the Middle East

KWM is pleased to confirm that it has established a new business to maintain a strategic presence in the UK, Europe & the Middle East.

18 January 2017